ES422966A1 - A method to inactivate a virus. (Machine-translation by Google Translate, not legally binding) - Google Patents

A method to inactivate a virus. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES422966A1
ES422966A1 ES422966A ES422966A ES422966A1 ES 422966 A1 ES422966 A1 ES 422966A1 ES 422966 A ES422966 A ES 422966A ES 422966 A ES422966 A ES 422966A ES 422966 A1 ES422966 A1 ES 422966A1
Authority
ES
Spain
Prior art keywords
virus
translation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES422966A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES422966A1 publication Critical patent/ES422966A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10161—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18661—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18861—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for inactivating a virus, comprising lyophilizing the virus in the presence of a protein stabilizer and heating the virus and stabilizer preparation thus obtained at an elevated temperature for a sufficient time to complete the inactivation effect. (Machine-translation by Google Translate, not legally binding)
ES422966A 1973-02-07 1974-02-06 A method to inactivate a virus. (Machine-translation by Google Translate, not legally binding) Expired ES422966A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB593673 1973-02-07

Publications (1)

Publication Number Publication Date
ES422966A1 true ES422966A1 (en) 1976-06-01

Family

ID=9805407

Family Applications (1)

Application Number Title Priority Date Filing Date
ES422966A Expired ES422966A1 (en) 1973-02-07 1974-02-06 A method to inactivate a virus. (Machine-translation by Google Translate, not legally binding)

Country Status (8)

Country Link
JP (1) JPS49109520A (en)
AU (1) AU6525274A (en)
BE (1) BE810697A (en)
DE (1) DE2405675A1 (en)
ES (1) ES422966A1 (en)
FR (1) FR2215946A1 (en)
IL (1) IL44143A0 (en)
NL (1) NL7401610A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL191729C (en) * 1978-04-12 1996-05-03 Merck & Co Inc Stabilized vaccine.
JPS57114527A (en) * 1979-10-29 1982-07-16 Merck & Co Inc Vaccine stabilizer
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US4338335A (en) * 1980-02-05 1982-07-06 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
JPS577423A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Frozen or freeze-dried live measles vaccine
FR2505657A1 (en) * 1981-05-13 1982-11-19 Pasteur Institut IMPROVEMENTS IN LIVE STABILIZING AGENTS FOR THE PREPARATION OF VACCINES, AND STABILIZED VACCINES CONTAINING SAID STABILIZING AGENTS
FR2532548B1 (en) * 1982-09-03 1985-11-08 Pasteur Institut NOVEL PROCESS FOR THE PRODUCTION OF VACCINES HAVING A HIGH TITLE OF VIRUSES AND HIGHLY PURIFIED VACCINES, A HIGH TITLE OF VIRUSES, SO OBTAINED
US4695454A (en) * 1985-04-01 1987-09-22 New York Blood Center, Inc. Process for preparing hepatitis B surface antigen containing particles in novel forms which are highly immunogenic
JPH0759759B2 (en) * 1988-10-29 1995-06-28 株式会社日立製作所 Method and apparatus for descaling annealed stainless steel strip
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus

Also Published As

Publication number Publication date
JPS49109520A (en) 1974-10-18
DE2405675A1 (en) 1974-08-15
AU6525274A (en) 1975-08-07
BE810697A (en) 1974-08-06
NL7401610A (en) 1974-08-09
IL44143A0 (en) 1974-05-16
FR2215946A1 (en) 1974-08-30

Similar Documents

Publication Publication Date Title
IT1190792B (en) PROCEDURE FOR PREPARING BLOOD COAGULANT ENZYME COMPOSITIONS
ES422966A1 (en) A method to inactivate a virus. (Machine-translation by Google Translate, not legally binding)
SE7409644L (en) PARTICULAR POROST MATERIAL AND SET AND APPLIANCE FOR ITS MANUFACTURE.
NL7609735A (en) POLYALKEEN PREPARATIONS AND METHODS FOR PREPARING THEM.
SE7508070L (en) SET AND APPLIANCE FOR SHEET TREATMENT.
SE408790B (en) PROCEDURE AND APPLIANCE FOR HEATING, OF GLASS SHEETS
DK103412C (en) Method for stabilizing biologically active bacteria, bacterial metabolic products, viruses, sera and enzymes.
NL160018C (en) PROCESS FOR PREPARING AN ADHESIVE COMPOSITION MELTING ON HEATING, AND ADHESIVE MATERIAL OBTAINED BY THEIR USE.
ES418690A1 (en) Procedure for the preparation of di-metionil-di-metionina. (Machine-translation by Google Translate, not legally binding)
BE831581A (en) THERMOPLASTIC COPOLYESTERS MODIFIED BY CARBONATES, AND THEIR PREPARATION PROCESS
ES461346A1 (en) Protease inactivated appha-amylase preparations
ES331307A1 (en) Procedure for preparation of protein hydrolysates. (Machine-translation by Google Translate, not legally binding)
ES282863A1 (en) A procedure for preparing a dehydrated canned product (Machine-translation by Google Translate, not legally binding)
RO71428A (en) PROCESS FOR THE PREPARATION OF THE PROTEIN, BY FERMENTATION
ES279927A1 (en) Procedure for the preparation of a vaccine against foot-and-mouth disease (Machine-translation by Google Translate, not legally binding)
ATA165674A (en) SELECTIVE WEED CONTROL IN MOOD, COTTON, PEANUT AND RICE CULTURES
ES303964A1 (en) A method of softening rice to reduce your cooking time. (Machine-translation by Google Translate, not legally binding)
ES305871A1 (en) A procedure for the preparation of lupulo products rich in lupuline. (Machine-translation by Google Translate, not legally binding)
ES331077A1 (en) Procedure to prepare a vaccine. (Machine-translation by Google Translate, not legally binding)
SE7607816L (en) KITS AND APPLIANCES FOR COOKING ANIMAL MATERIAL, DIFFERENT FISH OR FISH MASS
ES193666U (en) Cigarette and perfected filter set. (Machine-translation by Google Translate, not legally binding)
ES404722A3 (en) Procedure for the manufacture of insulinic preparations injectable for clinical use. (Machine-translation by Google Translate, not legally binding)
ES299188A1 (en) Procedure for the polymerization of cyclic acetals (Machine-translation by Google Translate, not legally binding)
ES352758A1 (en) A procedure to prepare food products. (Machine-translation by Google Translate, not legally binding)
ES192703U (en) Cooking apparatus with hot spray or hot-closed space, perfected. (Machine-translation by Google Translate, not legally binding)